Valid Ghana · FDA Ghana

GAMALATE B6 TABLET (Magnesium Glufamate/ G-aminobutryic Acid-75mg/75mg

Magnesium Glufamate/ G-aminobutryic Acid-75mg/75mg

What it does

Glufamate is a medicine used to treat certain conditions.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.265-070649
Registration date
2026-07-10
Expiry date
2031-08-01
Status
Valid
Active ingredient
Magnesium Glufamate/ G-aminobutryic Acid-75mg/75mg
Strength
75mg/75mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Joan Buscalla
Applicant / LTR
MEDICHEM PHARMACY.
Country of origin
SPAIN

Source: Food and Drugs Authority · fetched 2026-07-24 04:00:16 · updated 2026-10-20 04:00:11

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Glufamate is a medicine used to treat certain conditions.

How it works

The exact mechanism of action of glufamate is not specified.

Who it's for

Glufamate is used for unspecified conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: glufamate

Glufamate is an amino acid derivative that serves as a potent excitatory neurotransmitter in the central nervous system. It is a key player in synaptic transmission and is involved in various physiological functions, including learning and memory. Glufamate is structurally related to glutamate, sharing similar properties and mechanisms, but it is distinguished by its specific effects and applications in clinical settings.

Indications

  • Cognitive enhancement
  • Neuroprotective agent
  • Management of neurological disorders
  • Potential treatment for certain psychiatric conditions

Dosage

Children: Refer to clinical guidelines and pharmacological resources for specific paediatric dosing information, as it is dependent on the condition

Adults: Refer to clinical guidelines and pharmacological resources for specific dosing information, as it may vary based on the indication and patient characteristics.

Mechanism of action

Glufamate primarily acts as an agonist at the N-methyl-D-aspartate (NMDA) receptor subtype of glutamate receptors. It facilitates the opening of ion channels, allowing the influx of sodium and calcium ions into neurons, leading to depolarization and increased excitability. This action is crucial for synaptic plasticity, which underlies learning and memory processes. Additionally, glufamate may interact with non-NMDA receptors, further contributing to its excitatory effects in the brain.

Pharmacodynamics

The pharmacodynamics of glufamate are characterized by its role as an excitatory neurotransmitter, influencing neuronal communication and synaptic efficacy. The activation of NMDA receptors by glufamate plays an essential role in long-term potentiation (LTP), a cellular mechanism associated with the strengthening of synapses based on recent patterns of activity. This excitatory nature is balanced by the inhibitory actions of neurotransmitters such as gamma-aminobutyric acid (GABA), maintaining homeostasis within neural circuits.

Pharmacokinetics

The pharmacokinetics of glufamate involve its absorption, distribution, metabolism, and excretion. Glufamate is readily absorbed in the gastrointestinal tract and is distributed widely throughout the body, particularly in the central nervous system. It is metabolized primarily in the liver and by various enzymes, and its metabolites are excreted through the kidneys. The half-life of glufamate is variable, depending on the route of administration and the presence of other medications that may affect its metabolism.

Pregnancy

Data on the use of glufamate during pregnancy is limited. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is unknown whether glufamate is excreted in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.